Literature DB >> 4268638

The site and mode of action of ET495 for the mediation of stereotyped behaviour in the rat.

B Costall, R J Naylor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4268638     DOI： 10.1007/bf00500645

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  22 in total

1.  Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

2.  The inhibition of catecholamine biosynthesis by apomorphine.

Authors:  M Goldstein; L S Freedman; T Backstrom
Journal:  J Pharm Pharmacol       Date:  1970-09       Impact factor: 3.765

3.  Evidence for a new type of dopamine receptor stimulating agent.

Authors:  H Corrodi; K Fuxe; U Ungerstedt
Journal:  J Pharm Pharmacol       Date:  1971-12       Impact factor: 3.765

4.  Evidence for dopamine receptor stimulation by apomorphine.

Authors:  N E Andén; A Rubenson; K Fuxe; T Hökfelt
Journal:  J Pharm Pharmacol       Date:  1967-09       Impact factor: 3.765

5.  Stereotaxic mapping of the monoamine pathways in the rat brain.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

6.  The role of telencephalic dopaminergic systems in the mediation of apomorphine-stereotyped behaviour.

Authors:  B Costall; R J Naylor
Journal:  Eur J Pharmacol       Date:  1973-10       Impact factor: 4.432

Review 7.  Mode of action of psychomotor stimulant drugs.

Authors:  J M Van Rossum
Journal:  Int Rev Neurobiol       Date:  1970       Impact factor: 3.230

8.  On the mode of action of apomorphine.

Authors:  B Costall; R J Naylor
Journal:  Eur J Pharmacol       Date:  1973-03       Impact factor: 4.432

9.  Role of the tuberculum olfactorium in streotyped behaviour induced by apomorphine in the rat.

Authors:  G M McKenzie
Journal:  Psychopharmacologia       Date:  1972

Review 10.  Dopamine (3-hydroxytyramine) and brain function.

Authors:  O Hornykiewicz
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468
View more
  14 in total

1.  Differential regional and kinetics effects of piribedil and bromocriptine on dopamine metabolites: a brain microdialysis study in freely moving rats.

Authors:  R Pagliari; L Peyrin; O Crambes
Journal:  J Neural Transm Gen Sect       Date:  1995

2.  A new central direct dopaminergic stimulant: 1-(Coumaran-5-yl methyl)-4-(2-thiazolyl) piperazine hydrochloride (S 3608).

Authors:  J C Poignant; H Gressier; M Petitjean; G Regnier; R Canevari
Journal:  Experientia       Date:  1975-10-15

3.  Further aspects of nomifensine pharmacology.

Authors:  B Costall; R J Naylor
Journal:  Br J Clin Pharmacol       Date:  1977       Impact factor: 4.335

4.  Stimulation of a dopamine-sensitive adenylate cyclase in homogenates of rat striatum by a metabolite of piribedil (ET 495).

Authors:  R J Miller; L L Iversen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

5.  Changes in dopamine agonist and antagonist activity following temporary inactivation of the neostraitum.

Authors:  B Costall; R J Naylor; J C Pettit
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

6.  Specific asymmetric behavior induced by the direct chemical stimulation of neostriatal dopaminergic mechanisms.

Authors:  B Costall; R J Naylor
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

7.  Differential behavioral and biochemical effects of four dopaminergic agonists.

Authors:  G Gianutsos; K E Moore
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

8.  The Yawning elicited by alpha-melanocyte-stimulating hormone involves serotonergic-dopaminergic-cholinergic neuron link in rats.

Authors:  K Yamada; T Furukawa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-04       Impact factor: 3.000

9.  SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons.

Authors:  G R Breese; R A Mueller
Journal:  Eur J Pharmacol       Date:  1985-07-11       Impact factor: 4.432

10.  Dopamine agonist and antagonist activities of piribedil (ET495)and its metabolites.

Authors:  B Costall; R J Naylor
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.